A Special Issue with a Special Offer: Downloads for Donations*

The International Journal of Hyperthermia marked Breast Cancer Awareness Month with a timely Special Issue on the use of hyperthermia as a treatment for this disease. To mark the Special Issue, Informa Healthcare is donating $1 for each download* of the issue’s free-access articles to Susan G. Komen for the Cure®. Susan G. Komen for the Cure® is the world's largest breast cancer charity dedicated to education and research about causes, treatment and the search for a cure.

To date, there have been 3,512 downloads of articles from the Special Issue!

Hyperthermia, as its name suggests, involves raising tumor temperature and the treatment is used to fight disease. Modern advancements in hyperthermia biology have led to refinements for individualized thermochemotherapy approaches to treatments as well as interesting potential for exploiting hyperthermia in conjunction with cancer vaccines. Interest in hyperthermia as a treatment for breast cancer has led to significant advances and research activity which, in turn, has had a significant impact on treatment protocol. Thanks to the volume of research and the impact of published articles, the National Comprehensive Cancer Network (NCCN) now includes hyperthermia in their Breast Cancer Guidelines as a treatment for recurrent cancer.

“The breadth of contributions from the authors in this issue highlights the tremendous progress that has occurred in the role of hyperthermia for the treatment of breast cancer,” says Dr Joan Bull, Co-Guest Editor of the Special Edition.. “This subject has garnered broad national and international interest in this cutting-edge treatment for one of the world’s most high-profile and, unfortunately, prolific diseases.” To view the complete list of articles in the issue, please click here. For more information on the Special Issue, please contact Senior Managing Editor Didi Peng.


*This applies to a full text download of any article from the Special Issue (Volume 26 Issue 7) with a maximum donation of up to $1,500.00.

Computational Sciences in Drug Metabolism and Toxicology

This month Expert Opinion on Drug Metabolism and Toxicology is proud to introduce its first themed issue, focusing on Computational Sciences in Drug Metabolism and Toxicology.

Computational chemistry and bioinformatics have gained considerable importance in the pharmaceutical field to the extent that they are now integrated and indispensable to any R&D programme. This is particularly relevant in drug metabolism and toxicology studies, where in silico methods hold the potential to reduce the attrition rate throughout the drug development cycle and improve regulatory productivity and quality through faster, cheaper and better informed decision making.

Guest Edited by Dr Luis Valerio Jr., an internationally recognized expert in this topic, this issue is very unique and explores, among regulatory perspectives and reviews by leading experts, the variety of approaches in the field, their usage and development. Most importantly, it also stresses the limits of the tools and the need for their thorough understanding, testing and validation before implementation. In his free editorial, Dr Valerio Jr details the coverage of each article, and points out how these tools are evidence-based and represent an integrated science.

I hope you will find the articles insightful and thought provoking.

Joris Roulleau
Senior Editor